We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
This morning, the share price of synthetic biopharmaceutical companies headquartered in Rockville, Maryland, fell more than 14% and last year's drug administration